| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| AHR antagonist 2 |
AHR antagonist 2 |
2338747-54-7 |
詳細(xì)
|
| BAY 2416964 |
AHR antagonist 3 |
2242464-44-2 |
詳細(xì)
|
| Desethyl chloroquine diphosphate |
脫乙基氯喹二磷酸鹽 |
247912-76-1 |
詳細(xì)
|
| Ascomycin |
長川霉素 |
104987-12-4 |
詳細(xì)
|
| VAF347 |
2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]- |
574759-62-9 |
詳細(xì)
|
| Desethyl chloroquine |
羥基氯喹EP雜質(zhì)D-d5二鹽酸 |
1476-52-4 |
詳細(xì)
|
| Avatrombopag hydrochloride |
AVATROMBOPAG |
570403-17-7 |
詳細(xì)
|
| Disufenton sodium |
4-[[(1,1-二甲基乙基)氧化亞氨基]甲基]-1,3-苯二磺酸二鈉 |
168021-79-2 |
詳細(xì)
|
| FKBP12 PROTAC RC32 |
RC32 |
2375555-66-9 |
詳細(xì)
|
| MF63 |
2-(9-氯-1H-菲并[9,10-D]咪唑-2-基)-1,3-苯二甲腈 |
892549-43-8 |
詳細(xì)
|
| Sodium formononetin-3'-sulfonate |
芒柄花黃素-3'-磺酸鈉 |
949021-68-5 |
詳細(xì)
|
| PROTAC FKBP Degrader-3 |
PROTAC FKBP Degrader-3 |
2079056-43-0 |
詳細(xì)
|
| Ibuprofen Impurity K |
布洛芬EP雜質(zhì)K |
43153-07-7 |
詳細(xì)
|
| J14 |
J-14 |
1043854-13-2 |
詳細(xì)
|
| Soyasaponin II |
大豆皂苷II |
55319-36-3 |
詳細(xì)
|
| ADU-S100 disodium salt |
ADU-S100 DISODIUM SALT |
1638750-95-4 |
詳細(xì)
|
| Sulfo-ara-F-NMN |
CZ-48 |
1374663-29-2 |
詳細(xì)
|
| YKL-06-062 |
YKL-06-062 |
2172617-16-0 |
詳細(xì)
|
| SKI V |
2-(3,4-二羥基亞芐基)苯并呋喃-3(2H)-酮 |
24418-86-8 |
詳細(xì)
|
| Thiodigalactoside |
D-吡喃半乳糖 Β-D-硫代吡喃半乳糖苷 |
51555-87-4 |
詳細(xì)
|
| ADU-S100 ammonium salt |
ADU-S100銨鹽 |
1638750-96-5 |
詳細(xì)
|
| CAY10404 |
3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-TRIFLUOROMETHYLISOXAZOLE |
340267-36-9 |
詳細(xì)
|
| α-Chaconine |
α-卡茄堿 |
20562-03-2 |
詳細(xì)
|
| FKBP12 PROTAC dTAG-7 |
FKBP12 PROTAC DTAG-7 |
2064175-32-0 |
詳細(xì)
|
| 3,3'-Diiodo-L-thyronine |
3,3'-二碘甲腺原氨酸 |
4604-41-5 |
詳細(xì)
|
| PK11007 |
PK11007;PK-11007;PK 11007 |
874146-69-7 |
詳細(xì)
|
| KB02-SLF |
KB02-SLF |
2384184-40-9 |
詳細(xì)
|
| PTUPB |
PTUPB |
1287761-01-6 |
詳細(xì)
|
| SM-276001 |
SM-276001 |
473930-22-2 |
詳細(xì)
|
| YQ128 |
化合物YQ128 |
2454246-18-3 |
詳細(xì)
|
| Gnetol |
2,6,3',5'-四羥基二苯乙烯 |
86361-55-9 |
詳細(xì)
|
| Rifamycin S |
利福霉素S |
13553-79-2 |
詳細(xì)
|
| cGAMP |
C-GPAP |
849214-04-6 |
詳細(xì)
|
| Zapalog |
Zapalog |
1708091-24-0 |
詳細(xì)
|
| hPGDS-IN-1 |
化合物HPGDS-IN-1 |
1234708-04-3 |
詳細(xì)
|
| LNP023 |
LNP023 |
1644670-37-0 |
詳細(xì)
|
| MD2-TLR4-IN-1 |
MD2-TLR4-IN-1 |
2249801-12-3 |
詳細(xì)
|
| Complement C5-IN-1 |
COMPOUND C5-IN-1 (COMPOUND 7) |
2365402-67-9 |
詳細(xì)
|
| Succinobucol |
AGI 1067 |
216167-82-7 |
詳細(xì)
|
| GPI-1046 |
1-(1,2-二氧代-3,3-二甲基戊基)-L脯氨酸-(3-吡啶基)-丙酯 |
186452-09-5 |
詳細(xì)
|
| 2-Hydroxy Ibuprofen |
2-羥基布洛芬 |
51146-55-5 |
詳細(xì)
|
| Mesotrione |
甲基磺草酮 |
104206-82-8 |
詳細(xì)
|
| HPGDS inhibitor 2 |
GSK-2894631A |
2101626-26-8 |
詳細(xì)
|
| STING agonist-4 |
STING AGONIST-4 |
2138300-40-8 |
詳細(xì)
|
| G150 |
G150 |
2369751-30-2 |
詳細(xì)
|
| Apilimod |
阿吡莫德 |
541550-19-0 |
詳細(xì)
|
| StemRegenin 1 |
SR-1;SR1 |
1227633-49-9 |
詳細(xì)
|
| Imeglimin hydrochloride |
(6R)-1,6-二氫-N2,N2,6-三甲基-1,3,5-三嗪-2,4-二胺鹽酸鹽 |
775351-61-6 |
詳細(xì)
|
| OBA-09 |
856095-68-6 |
856095-68-6 |
詳細(xì)
|
| IFN alpha-IFNAR-IN-1 hydrochloride |
IFN ALPHA-IFNAR-IN-1鹽酸鹽 |
2070014-98-9 |
詳細(xì)
|
| Indomethacin-D4 |
吲哚美辛-D4 |
87377-08-0 |
詳細(xì)
|
| Levomefolic acid |
5-甲基四氫葉酸 |
31690-09-2 |
詳細(xì)
|
| Apilimod mesylate |
APILIMOD MESYLATE |
870087-36-8 |
詳細(xì)
|
| Indomethacin sodium hydrate |
吲哚美辛鈉 |
74252-25-8 |
詳細(xì)
|
| Naproxen sodium |
萘普生鈉 |
26159-34-2 |
詳細(xì)
|
| Naproxen |
萘普生 |
22204-53-1 |
詳細(xì)
|
| N-tert-Butyl-α-phenylnitrone |
N-叔丁基-#-苯基硝酮 |
3376-24-7 |
詳細(xì)
|
| Succinyl phosphonate trisodium salt |
SUCCINYL PHOSPHONATE TRISODIUM SALT |
864167-45-3 |
詳細(xì)
|
| Paradol |
6-姜酮酚 |
27113-22-0 |
詳細(xì)
|
| Eicosatetraynoic acid |
花生四烯酸 |
1191-85-1 |
詳細(xì)
|
| AM679 |
AM-679 |
1206880-66-1 |
詳細(xì)
|
| AB-680 |
AB-680 |
2105904-82-1 |
詳細(xì)
|
| Etoricoxib |
依托考昔 |
202409-33-4 |
詳細(xì)
|
| L-NIL |
L-NIL |
53774-63-3 |
詳細(xì)
|
| SKI II |
鞘氨醇激酶抑制劑 |
312636-16-1 |
詳細(xì)
|
| GW274150 |
化合物 T11518L |
210354-22-6 |
詳細(xì)
|
| Hesperidin |
橙皮甙 |
520-26-3 |
詳細(xì)
|
| AG-024322 |
CS-1092 |
837364-57-5 |
詳細(xì)
|
| ADH-503 |
ADH-503;ADH503;ADH 503 |
2055362-74-6 |
詳細(xì)
|
| Diclofenac diethylamine |
雙氯芬酸二乙胺 |
78213-16-8 |
詳細(xì)
|
| Motolimod |
MOTOLIMOD |
926927-61-9 |
詳細(xì)
|
| Efaproxiral sodium |
乙丙昔羅鈉 |
170787-99-2 |
詳細(xì)
|
| Diclofenac |
雙氯芬酸 |
15307-86-5 |
詳細(xì)
|
| Leukadherin-1 |
4-(5-((3-芐基-4-氧代-2-硫代噻唑烷-5-亞基)甲基)呋喃-2-基)苯甲酸 |
344897-95-6 |
詳細(xì)
|
| YKL-06-061 |
YKL 06-061 |
2172617-15-9 |
詳細(xì)
|
| Diclofenac Sodium |
雙氯芬酸鈉 |
15307-79-6 |
詳細(xì)
|
| 7,8-Dihydroneopterin |
7,8-二氫-D-新蝶呤 |
1218-98-0 |
詳細(xì)
|
| GW274150 phosphate |
GW274150 PHOSPHATE |
438542-15-5 |
詳細(xì)
|
| Silibinin |
水飛薊賓 |
22888-70-6 |
詳細(xì)
|
| Choline Fenofibrate |
非諾貝特膽堿 |
856676-23-8 |
詳細(xì)
|
| SC144 |
吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼 |
895158-95-9 |
詳細(xì)
|
| SC144 hydrochloride |
CS-2091 |
917497-70-2 |
詳細(xì)
|
| Urolithin C |
尿石素C |
165393-06-6 |
詳細(xì)
|
| MRT199665 |
MRT 199665 |
1456858-57-3 |
詳細(xì)
|
| Pentagamavunon-1 |
Pentagamavunon-1 |
27060-70-4 |
詳細(xì)
|
| GSK717 |
GSK717 |
1595278-21-9 |
詳細(xì)
|
| N-Acetyl-D-cysteine |
N-乙?；?D-半胱氨酸 |
26117-28-2 |
詳細(xì)
|
| Eltrombopag Olamine |
艾曲波帕乙醇胺 |
496775-62-3 |
詳細(xì)
|
| (S)-Flurbiprofen |
(S)-氟比洛芬 |
51543-39-6 |
詳細(xì)
|
| (Z)-Leukadherin-1 |
Benzoic acid, 4-[5-[(Z)-[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]- |
2055362-72-4 |
詳細(xì)
|
| DMNQ |
DMNQ |
6956-96-3 |
詳細(xì)
|
| Efaproxiral |
乙丙昔羅 |
131179-95-8 |
詳細(xì)
|
| Semapimod tetrahydrochloride |
5MG |
164301-51-3 |
詳細(xì)
|
| AP20187 |
AP 20187 |
195514-80-8 |
詳細(xì)
|
| Catalase |
過氧化氫酶 |
9001-05-2 |
詳細(xì)
|
| Diclofenac potassium |
雙氯芬酸鉀 |
15307-81-0 |
詳細(xì)
|
| AR-C102222 hydrochloride |
AR-C102222 HYDROCHLORIDE |
1781934-50-6 |
詳細(xì)
|
| BMS-1001 hydrochloride |
BMS-1001 |
2113650-04-5 |
詳細(xì)
|
| Tacrolimus |
他克莫司 |
104987-11-3 |
詳細(xì)
|
| OP-5244 |
|
2381268-71-7 |
詳細(xì)
|